The European Commission issued requests on 4 February for updated opinions from the Scientific Committee on Consumer Safety on octocrylene, homosalate and benzophenone-3, in light of concerns that led to their listing in 2019 as “higher priority” substances used in cosmetics with endocrine-disrupting potential.
The European Union’s Scientific Committee On Consumer Safety has nine months to reevaluate the safety of three UV filters currently permitted in cosmetics at specified levels, with a focus on the ingredients’ potential endocrine-disrupting properties.
The Commission issued requests on 4 February for updated SCCS opinions on octocrylene, homosalate and benzophenone-3, currently approved for use in cosmetic products as UV filters in...
Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”
AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.
Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”
